Private equity firms are aggressively targeting the women's health sector, drawn by what Kearney's Paula Bellostas Muguerza calls a $1 trillion investment gap in women's healthcare. The sector has seen increased activity from firms like Astorg, Cinven, and Nordic Capital, who are particularly focused on pathology assets.

This investment surge reflects growing recognition of women's healthcare as an underserved market. The pathology segment has become especially attractive, with firms seeking to consolidate diagnostic services and expand testing capabilities. The trend mirrors broader healthcare private equity strategies focused on specialized medical services.

A recent high-profile transaction underscores the sector's momentum: EyeSouth Partners sold for $1.1 billion to Cencora, having grown significantly under Olympus Partners' ownership. This deal highlights how private equity can scale specialized healthcare businesses through operational improvements and strategic acquisitions.